Hyaluronic Acid Viscosupplementation | Market Insights | Global | 2022
Overall, the HA viscosupplementation market has seen a substantial negative impact due to the COVID-19 pandemic. Although some procedures have begun to recover, a sizable proportion of HA viscosupplementation procedures are still being deferred due to COVID-19. That said, the market will continue to recover going forward as a larger proportion of the population is vaccinated. Beyond the impact of the pandemic, the global market for HA viscosupplementation will exhibit modest growth through 2030. While premium-priced 1-injection products will continue to become more popular over the forecast period, 3- and 5-injection products will continue to be preferred in some countries due to differences in product access, cost, and reimbursement.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for the US, Europe, Asia Pacific, and Brazil across an 11-year period.
